EGFR and lung carcinoma: A genetically engineered inducible EGFR L858R transgenic mouse model, identified as a model of human lung cancer development that can be used to assess the effectiveness of drugs (Taguchi et al., 2011; Politi et al., 2010), was used for investigating lung cancer progression in mice with or without an HFD.